GLP-1 Medications and Breast Cancer: What the Latest Research Really Means Surviving Breast Cancer Jun 9 5 min read New research on Ozempic, Wegovy, and other GLP-1 medications is raising questions about breast cancer risk, treatment outcomes, and survivorship
This leads many to wonder about the drug's effects, in particular: What happens when you stop taking Ozempic
Aparicio-Trejo OE, Tapia E, Briones-Herrera A, Martnez-Klimova E, Pedraza-Chaverri J (2021) Chapter 27Antioxidants and natural-derived products in the modulation of mitochondrial bioenergetics and dysfunction in chronic kidney disease models
Others prefer injecting on an empty stomach and waiting two to three hours before eating
Hepatitis Research and Treatment 2010